Tag: Graham Goodrich
Apnimed makes critical additions to C-suite
January 22, 2024HME News Staff
CAMBRIDGE, Mass. – Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacological therapies for the treatment of obstructive sleep apnea and related disorders, has named Graham Goodrich as chief commercial officer and Ted Harding as chief human resources officer. The company says the additions to the C-suite are critical as the company prepares to launch AD109, a potential nighttime oral treatment currently in Phase 3. “We are thrilled to have attracted two...
Apnimed, Graham Goodrich, Obstructive Sleep Apnea (OSA), oral therapy, Ted Harding
Sponsored Stories
Unlock the Future of Your Business: Download the VGM Playbook for 2025!
By VGM & AssociatesExclusive Look: The SOS Philippines Team in Action! (Watch the Video)
By Strategic Office SupportFrom Intake to Billing — SOS Handles It All for HME/DME Providers
By Strategic Office Support